CO6612270A2 - Método para preparar una capsula dura enterica y capsula dura enterica preparada por el mismo - Google Patents

Método para preparar una capsula dura enterica y capsula dura enterica preparada por el mismo

Info

Publication number
CO6612270A2
CO6612270A2 CO12171903A CO12171903A CO6612270A2 CO 6612270 A2 CO6612270 A2 CO 6612270A2 CO 12171903 A CO12171903 A CO 12171903A CO 12171903 A CO12171903 A CO 12171903A CO 6612270 A2 CO6612270 A2 CO 6612270A2
Authority
CO
Colombia
Prior art keywords
hard capsule
enteric hard
preparing
film
enteric
Prior art date
Application number
CO12171903A
Other languages
English (en)
Inventor
Jin Ryul Son
Hyon Ho Baek
Eun Hee Park
Sung Wan Lee
Min Gyu Song
Ja Hyun Cha
Jae Uk Cha
Won Hwa Ko
Original Assignee
Samsung Fine Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samsung Fine Chemicals Co Ltd filed Critical Samsung Fine Chemicals Co Ltd
Publication of CO6612270A2 publication Critical patent/CO6612270A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/077Manufacturing capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Manufacturing & Machinery (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención proporciona un método de preparar una cápsula dura entérica así como la cápsula obtenida con dicho método. En una modalidad preferida el método se caracteriza por las etapas de i) disolver un material base entérico, un auxiliar de formación de cápsulas y un agente neutralizante en agua, ii) calentar la composición resultante, iii) sumergir un punzón de moldeo en la composición para obtener una película, iv) mantener la película sobre el punzón de moldeo y vi) secar la película fijada. El método y las capsulas resultantes del mismo son útiles en el campo de las formulaciones farmacéuticas, particularmente en la administración de compuestos activos.
CO12171903A 2010-06-11 2012-10-01 Método para preparar una capsula dura enterica y capsula dura enterica preparada por el mismo CO6612270A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020100055470A KR101182827B1 (ko) 2010-06-11 2010-06-11 장용성 경질 캡슐의 제조방법 및 장용성 경질 캡슐

Publications (1)

Publication Number Publication Date
CO6612270A2 true CO6612270A2 (es) 2013-02-01

Family

ID=45098263

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12171903A CO6612270A2 (es) 2010-06-11 2012-10-01 Método para preparar una capsula dura enterica y capsula dura enterica preparada por el mismo

Country Status (10)

Country Link
US (1) US8710105B2 (es)
EP (1) EP2579853B1 (es)
JP (1) JP5876875B2 (es)
KR (1) KR101182827B1 (es)
BR (1) BR112012025406B1 (es)
CO (1) CO6612270A2 (es)
ES (1) ES2574758T3 (es)
SI (1) SI2579853T1 (es)
TW (1) TWI501761B (es)
WO (1) WO2011155686A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2832372A4 (en) * 2012-03-26 2015-11-11 Samsung Fine Chemicals Co Ltd COMPOSITION FOR HARD GASTRO-RESISTANT GELULES AND HARD-GARDEN RESISTANT HARD-GEL PREPARED USING THE COMPOSITION
CA2870134C (en) 2012-05-02 2020-04-28 Capsugel France SAS Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas)
IN2015DN00427A (es) 2012-07-23 2015-06-19 Samsung Fine Chemicals Co Ltd
KR102008417B1 (ko) 2012-12-04 2019-08-08 롯데정밀화학 주식회사 적층 필름 및 필름 적층방법
KR102085330B1 (ko) 2012-12-05 2020-03-05 롯데정밀화학 주식회사 두께 균일성이 개선된 경질 캡슐
JP5836980B2 (ja) 2013-01-11 2015-12-24 信越化学工業株式会社 薬物含有粒子、固形製剤及び薬物含有粒子の製造方法
EP3065720A1 (en) 2013-11-04 2016-09-14 Capsugel Belgium NV Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
WO2016032791A1 (en) * 2014-08-27 2016-03-03 Dow Global Technologies Llc Esterified cellulose ethers of low acetone-insoluble content
US10471152B2 (en) 2014-08-29 2019-11-12 Capsugel Belgium Nv Colloidal dispersion comprising HPMCAS
CN104546487B (zh) * 2014-12-05 2017-10-17 丹东金丸集团有限公司 全自动肠溶胶囊生产线
CN104890157A (zh) * 2015-05-26 2015-09-09 绍兴海邦药业有限公司 一种多功能空心胶囊制作模具
CN104890156A (zh) * 2015-05-26 2015-09-09 绍兴海邦药业有限公司 一种具有可换性的空心胶囊模具
ES2845688T3 (es) 2016-01-28 2021-07-27 Capsugel Belgium Nv Composiciones y cápsulas duras resultantes que comprenden concentrados alimentarios colorantes hidrófilos
EP3272340A1 (en) 2016-07-22 2018-01-24 Capsugel Belgium NV Acid resistant capsules
KR102086461B1 (ko) * 2018-01-19 2020-03-09 주식회사 서흥 열겔화 히프로멜로오스 하드 캡슐의 제조방법
KR102182326B1 (ko) * 2019-02-19 2020-11-24 주식회사 서흥 내산성 셀룰로오스 캡슐의 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3955E (es) * 1975-04-17 1981-10-15 Parke Davis & Co Procedimiento para producir una capsula farmaceutica que tiene propiedades entericas
US4138013A (en) 1976-08-27 1979-02-06 Parke, Davis & Company Enteric capsules
DE3167521D1 (en) * 1981-01-22 1985-01-17 Capsugel Ag A process for producing a pharmaceutical capsule having enteric properties
JPH0634807B2 (ja) * 1989-06-08 1994-05-11 信越化学工業株式会社 医薬用硬質カプセルの製造方法
JP3449253B2 (ja) * 1998-10-29 2003-09-22 シオノギクオリカプス株式会社 硬質カプセルの製造方法
TWI232761B (en) * 2000-07-01 2005-05-21 Pharmaceutical Ind Tech & Dev Capsule preparation for oral administration and the preparation method thereof
JP2006016372A (ja) * 2004-07-05 2006-01-19 Shionogi Qualicaps Co Ltd 腸溶性硬カプセル剤
US20080134937A1 (en) * 2005-05-25 2008-06-12 Joo Hwan Yang Cellulose hard capsule enhancing mechanical film strength
KR101170283B1 (ko) * 2006-10-27 2012-07-31 화이자 프로덕츠 인코포레이티드 하이드록시프로필 메틸 셀룰로스 경질 캡슐 및 이의 제조 방법
KR101705204B1 (ko) * 2009-09-11 2017-02-09 롯데정밀화학 주식회사 장용성 경질 캡슐용 수성 조성물, 장용성 경질 캡슐의 제조방법 및 장용성 경질 캡슐

Also Published As

Publication number Publication date
EP2579853A1 (en) 2013-04-17
JP5876875B2 (ja) 2016-03-02
ES2574758T3 (es) 2016-06-21
SI2579853T1 (sl) 2016-09-30
EP2579853A4 (en) 2015-04-29
US20130072579A1 (en) 2013-03-21
BR112012025406B1 (pt) 2021-10-13
BR112012025406A2 (pt) 2016-07-05
JP2013528209A (ja) 2013-07-08
WO2011155686A1 (en) 2011-12-15
KR101182827B1 (ko) 2012-09-14
US8710105B2 (en) 2014-04-29
KR20110135630A (ko) 2011-12-19
EP2579853B1 (en) 2016-05-25
TWI501761B (zh) 2015-10-01
TW201143757A (en) 2011-12-16

Similar Documents

Publication Publication Date Title
CO6612270A2 (es) Método para preparar una capsula dura enterica y capsula dura enterica preparada por el mismo
DOP2015000051A (es) Formulaciones acuosas estables de adalimumab
ECSP13012368A (es) Composiciones farmacéuticas de co-cristales de tramadol y coxibs
NZ631100A (en) Soft chewable pharmaceutical products
BR112014013175A8 (pt) composições de liberação prolongada baseadas em lipídios anfipáticos e processo para preparar comprimidos de composição de liberação prolongada
CR20140399A (es) Pirrolidina-2-carboxamidas sustituidas
GT201600017A (es) Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CR20120316A (es) Procesos para la fabricación de un agente farmacéuticamente activo
CR20140005A (es) Una nueva composición terapéutica que contiene apomorfina como principio activo
CL2016002560A1 (es) Forma de dosificación farmacéutica sólida oral que comprende siponimod, un agente protector de la humedad y opcionalmente un excipiente farmacéutico; procedimiento de preparación.
GT201700280A (es) Formulación sólida oral que contiene irinotecán y método de preparación de la misma
BR112022000982A2 (pt) Forma de dosagem veterinária mastigável macia
CR20150266A (es) Formulaciones de liberación modificada para oprozomib
CO2019011547A2 (es) Compuesto sólido cristalino novedoso de clorhidrato de 3-fenil-4-propil-1-(piridin-2-il)-1h-pirazol-5-ol
PH12015502556A1 (en) Modified release formulation
EA201500043A1 (ru) Лекарственная форма для продленного высвобождения действующих веществ
BR112016015190A2 (pt) Composição farmacêutica não contendo antioxidante e método de preparação da mesma
BR112017025395A2 (pt) formulações farmacêuticas para liberação prolongada de sebacoil éster de dinalbufina
MX2015010486A (es) Composicion masticable para administracion oral y proceso para preparar la misma.
ES2403549R1 (es) Co-cristales de agomelatina con formadores de co-cristales
AR100850A1 (es) Composición farmacéutica que comprende desmopresina y un agente estabilizador
EA029062B9 (ru) Способ получения фармацевтической композиции и продукт способа
AR089590A1 (es) Sal de bromhidrato de pridopidina
ITUA20163329A1 (it) Dispositivo medico, particolarmente per la ricostruzione mammaria atto ad evitare la ptosi dopo impianto di protesi
IN2014MU01178A (es)

Legal Events

Date Code Title Description
FC Application refused